Calton & Associates Inc. Sells 1,821 Shares of CVS Health Co. (NYSE:CVS)

Calton & Associates Inc. lowered its position in CVS Health Co. (NYSE:CVS) by 41.5% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,570 shares of the pharmacy operator’s stock after selling 1,821 shares during the period. Calton & Associates Inc.’s holdings in CVS Health were worth $205,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the company. SOA Wealth Advisors LLC. raised its stake in shares of CVS Health by 4.9% in the fourth quarter. SOA Wealth Advisors LLC. now owns 2,859 shares of the pharmacy operator’s stock valued at $226,000 after acquiring an additional 133 shares during the last quarter. Apella Capital LLC raised its stake in shares of CVS Health by 4.2% in the fourth quarter. Apella Capital LLC now owns 3,378 shares of the pharmacy operator’s stock valued at $272,000 after acquiring an additional 136 shares during the last quarter. Prairie Sky Financial Group LLC increased its holdings in shares of CVS Health by 4.1% in the fourth quarter. Prairie Sky Financial Group LLC now owns 3,612 shares of the pharmacy operator’s stock valued at $285,000 after purchasing an additional 141 shares in the last quarter. WealthShield Partners LLC increased its holdings in shares of CVS Health by 3.2% in the fourth quarter. WealthShield Partners LLC now owns 4,498 shares of the pharmacy operator’s stock valued at $355,000 after purchasing an additional 141 shares in the last quarter. Finally, Sugarloaf Wealth Management LLC increased its holdings in shares of CVS Health by 9.5% in the fourth quarter. Sugarloaf Wealth Management LLC now owns 1,639 shares of the pharmacy operator’s stock valued at $129,000 after purchasing an additional 142 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

Insider Transactions at CVS Health

In other news, Director Edward J. Ludwig acquired 1,000 shares of the stock in a transaction dated Thursday, May 2nd. The shares were bought at an average cost of $53.88 per share, for a total transaction of $53,880.00. Following the purchase, the director now directly owns 21,630 shares of the company’s stock, valued at $1,165,424.40. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.24% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of analysts recently weighed in on the stock. TD Cowen lowered shares of CVS Health from a “buy” rating to a “hold” rating and lowered their price target for the company from $99.00 to $59.00 in a report on Tuesday, May 7th. Truist Financial reissued a “buy” rating and issued a $66.00 price target (down previously from $90.00) on shares of CVS Health in a report on Thursday, May 2nd. Wells Fargo & Company lowered their price target on shares of CVS Health from $76.00 to $60.00 and set an “equal weight” rating for the company in a report on Tuesday, May 7th. Piper Sandler lifted their target price on shares of CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a report on Friday, March 15th. Finally, Argus lowered their target price on shares of CVS Health from $100.00 to $80.00 and set a “buy” rating for the company in a report on Wednesday, May 8th. Eleven investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $75.05.

CVS Health Trading Up 1.3 %

Shares of NYSE:CVS opened at $59.09 on Friday. The company’s 50-day moving average price is $59.56 and its two-hundred day moving average price is $70.19. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.81 and a quick ratio of 0.61. CVS Health Co. has a one year low of $52.77 and a one year high of $83.25. The stock has a market capitalization of $74.18 billion, a PE ratio of 10.38, a price-to-earnings-growth ratio of 0.56 and a beta of 0.53.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing the consensus estimate of $1.69 by ($0.38). CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The business had revenue of $88.44 billion for the quarter, compared to the consensus estimate of $89.33 billion. During the same period last year, the firm earned $2.20 earnings per share. The company’s quarterly revenue was up 3.7% compared to the same quarter last year. On average, equities analysts forecast that CVS Health Co. will post 7.02 EPS for the current fiscal year.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.